Donald Trump’s Executive Order Maintains the Pain on UnitedHealth Stock (UNH)
UnitedHealth (UNH) has experienced significant volatility, with its stock down approximately 55% from its 52-week high. Once viewed as a stable blue-chip stalwart, the company trades more like a distressed asset amid a series of negative developments. Rising medical costs, an unexpected CEO departure, and heightened regulatory uncertainty stemming from former President Trump’s recent executive order on drug pricing have all contributed to investor unease. While the stock may appear attractively